MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
AMZN   3,182.63 (+3.29%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
AMZN   3,182.63 (+3.29%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
AMZN   3,182.63 (+3.29%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
AMZN   3,182.63 (+3.29%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
Log in

NASDAQ:NITENightstar Therapeutics News Headlines

Notice: This company has been marked as potentially delisted and may not be actively trading.
$25.41
0.00 (0.00 %)
(As of 06/7/2019)
Add
Compare
Today's Range
$25.41
Now: $25.41
$25.41
50-Day Range
$25.41
MA: $25.41
$25.41
52-Week Range
$9.59
Now: $25.41
$29.55
Volume40 shs
Average Volume185,808 shs
Market Capitalization$852.25 million
P/E RatioN/A
Dividend YieldN/A
Beta2.84

Headlines

Nightstar Therapeutics (NASDAQ NITE) News Headlines

Source:
DateHeadline
Dyne Therapeutics Appoints David Lubner to Board of DirectorsDyne Therapeutics Appoints David Lubner to Board of Directors
www.businesswire.com - April 23 at 12:26 PM
Nightstar Therapeutics: Nightstar Therapeutics to Present at Jefferies 2018 Global Healthcare ConferenceNightstar Therapeutics: Nightstar Therapeutics to Present at Jefferies 2018 Global Healthcare Conference
www.bloomberg.com - January 2 at 12:44 AM
What Type Of Shareholder Owns Cryptanite Blockchain Technologies Corp.'s (CNSX:NITE)?What Type Of Shareholder Owns Cryptanite Blockchain Technologies Corp.'s (CNSX:NITE)?
finance.yahoo.com - August 28 at 5:54 PM
Hedge Funds Have Never Been This Bullish On Nightstar Therapeutics plc (NITE)Hedge Funds Have Never Been This Bullish On Nightstar Therapeutics plc (NITE)
finance.yahoo.com - June 24 at 6:08 PM
Biogen Inc.: Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 MillionBiogen Inc.: Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million
www.bloomberg.com - June 7 at 6:00 PM
Nightstar Therapeutics PLC Completion of Acquisition by BiogenNightstar Therapeutics PLC Completion of Acquisition by Biogen
feeds.benzinga.com - June 7 at 7:46 AM
Nightstar Therapeutics plc Court Approval Received in Connection With Acquisition by BiogenNightstar Therapeutics plc Court Approval Received in Connection With Acquisition by Biogen
finance.yahoo.com - June 5 at 10:34 AM
Nightstar Therapeutics plc Update to Timetable Relating to the Acquisition by BiogenNightstar Therapeutics plc Update to Timetable Relating to the Acquisition by Biogen
finance.yahoo.com - May 29 at 9:54 AM
If You Had Bought Cryptanite Blockchain Technologies (CNSX:NITE) Stock A Year Ago, You'd Be Sitting On A 75% Loss, TodayIf You Had Bought Cryptanite Blockchain Technologies (CNSX:NITE) Stock A Year Ago, You'd Be Sitting On A 75% Loss, Today
finance.yahoo.com - May 28 at 10:32 AM
Nightstar Therapeutics PLC Shareholders Approve Scheme of Arrangement for Acquisition By Biogen at General Meeting and Court Meeting Held on 8 May 2019Nightstar Therapeutics PLC Shareholders Approve Scheme of Arrangement for Acquisition By Biogen at General Meeting and Court Meeting Held on 8 May 2019
finance.yahoo.com - May 8 at 10:32 AM
Rocket Pharmaceuticals: A Fully Fueled Gene Therapy PipelineRocket Pharmaceuticals: A Fully Fueled Gene Therapy Pipeline
seekingalpha.com - May 7 at 5:14 PM
Nightstar Therapeutics: Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote "FOR" Proposed Acquisition by BiogenNightstar Therapeutics: Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote "FOR" Proposed Acquisition by Biogen
www.finanznachrichten.de - April 26 at 10:19 AM
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote "FOR" Proposed Acquisition by BiogenLeading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote "FOR" Proposed Acquisition by Biogen
www.marketwatch.com - April 26 at 10:19 AM
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote “FOR” Proposed Acquisition by BiogenLeading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote “FOR” Proposed Acquisition by Biogen
finance.yahoo.com - April 26 at 10:19 AM
Biogen Looks to 23 Clinical Programs for GrowthBiogen Looks to 23 Clinical Programs for Growth
finance.yahoo.com - April 25 at 5:13 PM
Nightstar Therapeutics plc Announcement of Expiry of HSR Waiting Period and Satisfaction of Antitrust ConditionNightstar Therapeutics plc Announcement of Expiry of HSR Waiting Period and Satisfaction of Antitrust Condition
finance.yahoo.com - April 16 at 12:01 PM
Nightstar (NITE) Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Nightstar Therapeutics Plc is Fair to Nightstar Shareholders – NITENightstar (NITE) Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Nightstar Therapeutics Plc is Fair to Nightstar Shareholders – NITE
finance.yahoo.com - April 15 at 5:17 PM
Recommended Acquisition of Nightstar Therapeutics plc by Tungsten Bidco Limited, a Wholly-Owned Subsidiary of Biogen Switzerland Holdings GmbH; Posting of Scheme DocumentRecommended Acquisition of Nightstar Therapeutics plc by Tungsten Bidco Limited, a Wholly-Owned Subsidiary of Biogen Switzerland Holdings GmbH; Posting of Scheme Document
finance.yahoo.com - April 9 at 11:51 AM
Why Nightstar Therapeutics Stock Skyrocketed 71% in MarchWhy Nightstar Therapeutics Stock Skyrocketed 71% in March
finance.yahoo.com - April 3 at 12:28 PM
Biogen - Pipeline Setback Looks To Create An OpportunityBiogen - Pipeline Setback Looks To Create An Opportunity
seekingalpha.com - March 25 at 4:45 PM
Nightstar Therapeutics PLCNightstar Therapeutics PLC
www.bloomberg.com - March 19 at 11:30 AM
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOsThe Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs
feeds.benzinga.com - March 10 at 4:45 PM
Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?
finance.yahoo.com - March 8 at 5:11 PM
Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & MoreBiotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More
www.zacks.com - March 6 at 10:35 AM
Analysts Laud Biogens M&A Strategy Following Deal to Buy Gene Therapy Company NightstarAnalysts Laud Biogen's M&A Strategy Following Deal to Buy Gene Therapy Company Nightstar
finance.yahoo.com - March 5 at 5:12 PM
How Much Does Biogen Gain From Its $800 Million Gene Therapy Buyout?How Much Does Biogen Gain From Its $800 Million Gene Therapy Buyout?
finance.yahoo.com - March 5 at 5:12 PM
Company News For Mar 5, 2019Company News For Mar 5, 2019
finance.yahoo.com - March 5 at 11:29 AM
Are Nightstar Shareholders Getting Enough in the Buyout?Are Nightstar Shareholders Getting Enough in the Buyout?
247wallst.com - March 4 at 4:56 PM
Nightstar Soars as Biogen to Buy Gene Therapy Company for $877 MillionNightstar Soars as Biogen to Buy Gene Therapy Company for $877 Million
www.thestreet.com - March 4 at 4:56 PM
Why Nightstar Therapeutics Stock Is Soaring TodayWhy Nightstar Therapeutics Stock Is Soaring Today
finance.yahoo.com - March 4 at 4:56 PM
Biogen Bets On Gene Therapy, Agrees To Acquire Nightstar For $800MBiogen Bets On Gene Therapy, Agrees To Acquire Nightstar For $800M
feeds.benzinga.com - March 4 at 9:55 AM
Syncona to cash in as Biogen acquires NightstarSyncona to cash in as Biogen acquires Nightstar
www.lse.co.uk - March 4 at 8:06 AM
Biogen to buy Nightstar Therapeutics in a $800 million cash dealBiogen to buy Nightstar Therapeutics in a $800 million cash deal
www.cnbc.com - March 4 at 8:06 AM
Nightstar Therapeutics plc reaches agreement to be acquired by BiogenNightstar Therapeutics plc reaches agreement to be acquired by Biogen
www.marketwatch.com - March 4 at 8:06 AM
Nightstar Therapeutics PLC ADRNightstar Therapeutics PLC ADR
www.barrons.com - January 17 at 4:50 PM
Nightstar Therapeutics PLC Sponsored ADR (NITE)Nightstar Therapeutics PLC Sponsored ADR (NITE)
www.zacks.com - January 15 at 4:49 PM
Form 3/A Nightstar Therapeutics For: Jan 01 Filed by: FELLOWS DAVID A - StreetInsider.comForm 3/A Nightstar Therapeutics For: Jan 01 Filed by: FELLOWS DAVID A - StreetInsider.com
www.streetinsider.com - January 11 at 10:12 AM
Form 3 Nightstar Therapeutics For: Jan 01 Filed by: McArthur James G - StreetInsider.comForm 3 Nightstar Therapeutics For: Jan 01 Filed by: McArthur James G - StreetInsider.com
www.streetinsider.com - January 3 at 9:33 AM
Form 3 Nightstar Therapeutics For: Jan 01 Filed by: Ong Tuyen - StreetInsider.comForm 3 Nightstar Therapeutics For: Jan 01 Filed by: Ong Tuyen - StreetInsider.com
www.streetinsider.com - January 3 at 9:33 AM
Is Nightstar Therapeutics plc (NITE) Going to Burn These Hedge Funds?Is Nightstar Therapeutics plc (NITE) Going to Burn These Hedge Funds?
finance.yahoo.com - December 23 at 8:49 AM
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.